GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance

U.S. Markets closed

Gilead Sciences Inc. (GILD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
69.94+0.57 (+0.82%)
At close: 4:00PM EST
People also watch
CELGBIIBAMGNREGNBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close69.37
Open69.32
Bid69.83 x 200
Ask69.94 x 300
Day's Range69.05 - 70.07
52 Week Range65.38 - 103.10
Volume6,695,209
Avg. Volume10,820,400
Market Cap91.62B
Beta1.03
PE Ratio (TTM)7.04
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (3.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Gilead, AbbVie Could Perk Up On Merck's Hep C Downfall: Leerink
    Investor's Business Daily21 hours ago

    Gilead, AbbVie Could Perk Up On Merck's Hep C Downfall: Leerink

    Gilead and AbbVie will benefit from Merck's decision to take a $2.9 billion impairment charge on a hepatitis C drug, Leerink says.

  • Forbesyesterday

    NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017

    Todd Hagopian recently identified five sub-sectors of Biotech poised for the best potential returns under President Trump. Today Todd gives us a deep dive into NASH (Nonalcoholic Steatohepatitis), the sub-sector that he is most excited about for 2017.

  • Barrons.comyesterday

    Ten Stocks That Still Look Cheap

    As markets continue to rocket to new highs, investors may be wondering if there are any bargains left. Jefferies' Brian Abrahams and his team have some suggestions. While major indexes are bumping up against ...